Study directory

Depression studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
6115studies shown
Showing 1,369-1,380 of 6,115
Drug study icon
CompletedNCT02417064

Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant for treatment-resistant depression

This study is completed in the United States, in France, in Canada, .... It is testing efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant for treatment-resistant depression.

Multiple locations, including Birmingham
Why is this study shown?

This study is directly about Depression.

DepressionDrugA study involving a medication or substance.From 18 Years to 64 Years
Countries
United States, France, Canada, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
CompletedNCT02418585

Efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant for treatment-resistant depression

This study is completed in the United States, in Czechia, in Germany, .... It is testing efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant for treatment-resistant depression.

Multiple locations, including Birmingham
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 64 Years
Countries
United States, Czechia, Germany, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
CompletedNCT05800860

A study of GH001 in people with Treatment-resistant Depression

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Pilsen
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 64 Years
Countries
Czechia, Germany, Ireland, ...
Sponsor
GH Research Ireland Limited
Condition
Depression
Drug study icon
CompletedNCT05870540

BPL-003 Efficacy and Safety for treatment-resistant depression

This study is completed in the United States, in Australia, in the United Kingdom, .... It is testing BPL-003 Efficacy and Safety for treatment-resistant depression.

Multiple locations, including Birmingham
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 75 Years
Countries
United States, Australia, United Kingdom, ...
Sponsor
Beckley Psytech Limited
Condition
Depression
Device study icon
Active Not RecruitingNCT00565617

Epidural Cortical Stimulation for Depression

This summary needs review. Please check the official study record and contact the research team for details.

In Charleston
Why is this study shown?

This study is directly about Depression.

DepressionDeviceFrom 21 Years to 80 Years
Countries
United States
Sponsor
Medical University of South Carolina
Condition
Depression
Device study icon
CompletedNCT06166082

Intensive Accelerated iTBS for the Treatment-Resistant Depression

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Baoding
Why is this study shown?

This study is directly about Depression.

DepressionDeviceFrom 22 Years to 65 Years
Countries
China
Sponsor
Changping Laboratory
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.